Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Balaxi Pharmaceuticals Ltd

NSE: BALAXI · Pharmaceuticals & Biotechnology · 17 announcements

Share price
₹22.76
Market cap
₹125.7 Cr
Revenue (annual)
₹270.2 Cr
Net profit (annual)
₹1.42 Cr
P/E (TTM)
51.8×Sector 47.4×
Promoter holding
65.99%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

12:58 IST NSE
Business Update

Balaxi Pharmaceuticals Business Update

Balaxi Pharmaceuticals has received WHO-GMP certification for its first pharmaceutical formulation manufacturing facility in Telangana. The facility has commenced manufacturing initially approved products for international markets.

13:20 IST NSE
Business Update

Balaxi Pharmaceuticals Business Update

Balaxi Pharmaceuticals Limited has released its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26. The report forms part of the company's Annual Report.